163 related articles for article (PubMed ID: 21653322)
21. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Kennedy-Nasser AA; Leung KS; Mahajan A; Weiss HL; Arce JA; Gottschalk S; Carrum G; Khan SP; Heslop HE; Brenner MK; Bollard CM; Krance RA
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1277-84. PubMed ID: 17162209
[TBL] [Abstract][Full Text] [Related]
22. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia.
Bayever E; Champlin R; Ho W; Lenarsky C; Storch S; Ladisch S; Gale RP; Feig SA
J Pediatr; 1984 Dec; 105(6):920-5. PubMed ID: 6389812
[TBL] [Abstract][Full Text] [Related]
23. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
[TBL] [Abstract][Full Text] [Related]
24. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
[TBL] [Abstract][Full Text] [Related]
25. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.
Socié G; Henry-Amar M; Cosset JM; Devergie A; Girinsky T; Gluckman E
Blood; 1991 Jul; 78(2):277-9. PubMed ID: 2070065
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow failure in children with acute liver failure.
Tung J; Hadzic N; Layton M; Baker AJ; Dhawan A; Rela M; Heaton ND; Mieli-Vergani G
J Pediatr Gastroenterol Nutr; 2000 Nov; 31(5):557-61. PubMed ID: 11144443
[TBL] [Abstract][Full Text] [Related]
27. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.
Guardiola P; Socié G; Li X; Ribaud P; Devergie A; Espérou H; Richard P; Traineau R; Janin A; Gluckman E
Blood; 2004 Jan; 103(1):73-7. PubMed ID: 12946993
[TBL] [Abstract][Full Text] [Related]
28. Marrow transplantation in hepatitis-associated aplastic anemia.
Witherspoon RP; Storb R; Shulman H; Buckner CD; Deeg HJ; Clift RA; Sanders JE; Doney K; McDonald G; Sullivan KM
Am J Hematol; 1984 Oct; 17(3):269-78. PubMed ID: 6383025
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for secondary poor graft function after bone marrow transplantation in children with acquired aplastic anemia.
Hama A; Muramatsu H; Narita A; Nishikawa E; Kawashima N; Nishio N; Kojima S; Takahashi Y
Pediatr Transplant; 2020 Nov; 24(7):e13828. PubMed ID: 32876388
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome after bone marrow transplantation for severe aplastic anemia.
Ades L; Mary JY; Robin M; Ferry C; Porcher R; Esperou H; Ribaud P; Devergie A; Traineau R; Gluckman E; Socié G
Blood; 2004 Apr; 103(7):2490-7. PubMed ID: 14656884
[TBL] [Abstract][Full Text] [Related]
31. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
[TBL] [Abstract][Full Text] [Related]
32. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751
[TBL] [Abstract][Full Text] [Related]
33. Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
Ahn MJ; Choi JH; Lee YY; Choi IY; Kim IS; Yoon SS; Park SY; Kim BK; Suh C; Son HJ; Jung CW; Lee JH; Sung JM; Im SA; Oh D; Jung SY; Yoon HJ; Cho KS; Lee JA; Yuh YJ; Kim SR; Ki M
Int J Hematol; 2003 Aug; 78(2):133-8. PubMed ID: 12953807
[TBL] [Abstract][Full Text] [Related]
34. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
Anderlini P; Wu J; Gersten I; Ewell M; Tolar J; Antin JH; Adams R; Arai S; Eames G; Horwitz ME; McCarty J; Nakamura R; Pulsipher MA; Rowley S; Leifer E; Carter SL; DiFronzo NL; Horowitz MM; Confer D; Deeg HJ; Eapen M
Lancet Haematol; 2015 Sep; 2(9):e367-75. PubMed ID: 26685770
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
[TBL] [Abstract][Full Text] [Related]
36. Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia.
Ramsay NK; Kim TH; McGlave P; Goldman A; Nesbit ME; Krivit W; Woods WG; Kersey JH
Blood; 1983 Sep; 62(3):622-6. PubMed ID: 6349713
[TBL] [Abstract][Full Text] [Related]
37. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.
Storb R; Weiden PL; Sullivan KM; Appelbaum FR; Beatty P; Buckner CD; Clift RA; Doney KC; Hansen J; Martin PJ
Blood; 1987 Jul; 70(1):116-21. PubMed ID: 3297199
[TBL] [Abstract][Full Text] [Related]
38. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
[TBL] [Abstract][Full Text] [Related]
39. Aplastic anemia after liver transplantation for fulminant liver failure.
Cattral MS; Langnas AN; Markin RS; Antonson DL; Heffron TG; Fox IJ; Sorrell MF; Shaw BW
Hepatology; 1994 Oct; 20(4 Pt 1):813-8. PubMed ID: 7927220
[TBL] [Abstract][Full Text] [Related]
40. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
Kojima S; Matsuyama T; Kato S; Kigasawa H; Kobayashi R; Kikuta A; Sakamaki H; Ikuta K; Tsuchida M; Hoshi Y; Morishima Y; Kodera Y
Blood; 2002 Aug; 100(3):799-803. PubMed ID: 12130489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
